参考文献/References:
[1] Ha?ssaguerre M,Ja?s P,Shah DC,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. 1998,339(10):659-666.
[2] Marrouche Nf,Brachmann J,Andresen D,et al. Catheter ablation for atrial fibrillation with heart failure[J]. 2018,378(5):417-427.
[3] Packer DL,Mark DB,Robb RA,et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality,stroke,bleeding,and cardiac arrest among patients with atrial fibrillation:the CABANA randomized clinical trial[J]. 2019,321(13):1261-1274.
[4] Ullah W,Mclean A,Tayebjee MH,et al. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data[J]. 2016,13(9):1761-1767.
[5] Kautzner J,Neuzil P,Lambert H,et al. EFFICAS Ⅱ:optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation[J]. 2015,17(8):1229-1235.
[6] Bradley CJ,Haines DE. Pulsed field ablation for pulmonary vein isolation in the treatment of atrial fibrillation[J]. J Cardiovasc Electrophysiol,2020,31(8):2136-2147.
[7] Neumann E,Schaefer-Ridder M,Wang Y,et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields[J]. 1982,1(7):841-845.
[8] Davalos RV,Mir IL,Rubinsky B.Tissue ablation with irreversible electroporation[J]. Ann Biomed Eng,2005,33(2):223-231.
[9] Lavee J,Onik G,Mikus P,et al. A novel nonthermal energy source for surgical epicardial atrial ablation:irreversible electroporation[J].Heart Surg Forum,2007,10(2):E162-E167.
[10] Wittkampf FH,van Driel VJ,Van Wessel H,et al. Feasibility of electroporation for the creation of pulmonary vein ostial lesions[J].J Cardiovasc Electrophysiol,2011,22(3):302-309.
[11] van Driel VJ,Neven KG,van Wessel H,et al. Pulmonary vein stenosis after catheter ablation:electroporation versus radiofrequency[J]. Circ Arrhythm Electrophysiol,2014,7(4):734-738.
[12] Reddy VY,Koruth J,Jais P,et al. Ablation of atrial fibrillation with pulsed electric fields:an ultra-rapid,tissue-selective modality for cardiac ablation[J]. JACC Clin Electrophysiol,2018,4(8):987-995.
[13] Padmanabhan D,Naksuk N,Killu Ak,et al. Electroporation of epicardial autonomic ganglia:Safety and efficacy in medium-term canine models[J]. 2019,30(4):607-615.
[14] Sugrue A,Maor E,Ivorra A,et al. Irreversible electroporation for the treatment of cardiac arrhythmias[J].Expert Rev Cardiovasc Ther,2018,16(5):349-360.
[15] Sugrue A,Vaidya VR,Livia C,et al. Feasibility of selective cardiac ventricular electroporation[J]. PLoS One,2020,15(2):e0229214.
[16] Koruth JS,Kuroki K,Iwasawa J,et al. Endocardial ventricular pulsed field ablation:a proof-of-concept preclinical evaluation[J]. Europace,2020,22(3):434-439.
[17] Reddy VY,Neuzil P,Koruth JS,et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation[J]. J Am Coll Cardiol,2019,74(3):315-326.
[18] Edd JF,Horowitz L,Davalos RV,et al. In vivo results of a new focal tissue ablation technique:irreversible electroporation[J].IEEE Trans Biomed Eng,2006,53(7):1409-1415.
[19] Rubinsky B,Onik G,Mikus P,et al. Irreversible electroporation:a new ablation modality--clinical implications[J].Technol Cancer Res Treat,2007,6(1):37-48.
[20] Rems L,Kasimova MA,Testa I,et al. Pulsed electric fields can create pores in the voltage sensors of voltage-gated ion channels[J].Biophys J,2020,119(1):190-205.
[21] Vizintin A,Vidmar J,Scancar J,et al. Effect of interphase and interpulse delay in high-frequency irreversible electroporation pulses on cell survival,membrane permeabilization and electrode material release[J]. Bioelectrochemistry,2020,134:107523.
[22] Kaminska I,Kotulska M,Stecka A,et al. Electroporation-induced changes in normal immature rat myoblasts (H9C2)[J]. Gen Physiol Biophys,2012,31(1):19-25.
[23] Skolucka N,Daczewska M,Saczko J,et al. ETM study of electroporation influence on cell morphology in human malignant melanoma and human primary gingival fibroblast cells[J].Asian Pac J Trop Biomed,2011,1(2):94-98.
[24] Stewart MT, Haines DE,Verma A,et al. Intracardiac pulsed field ablation:proof of feasibility in a chronic porcine model[J]. Heart Rhythm,2019,16(5):754-764.
[25] Neven K,van Es R,van Driel V,et al. Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus[J].Circ Arrhythm Electrophysiol,2017,10(5):e004672.
[26] van Driel VJ,Neven K,van Wessel H,et al. Low vulnerability of the right phrenic nerve to electroporation ablation[J].Heart Rhythm,2015,12(8):1838-1844.
[27] du Pré BC,van Driel VJ,van Wessel H,et al. Minimal coronary artery damage by myocardial electroporation ablation[J].Europace,2013,15(1):144-149.
[28] Koruth JS,Kuroki K,Kawamura I,et al. Pulsed field ablation versus radiofrequency ablation:esophageal injury in a novel porcine model[J]. Circ Arrhythm Electrophysiol,2020,13(3):e008303.
[29] Kuroki K,Whang W,Eggert C,et al. Ostial dimensional changes after pulmonary vein isolation:Pulsed field ablation vs radiofrequency ablation[J]. Heart Rhythm,2020,17(9):1528-1535.
[30] Koruth J,Kuroki K,Iwasawa J,et al. Preclinical evaluation of pulsed field ablation:electrophysiological and histological assessment of thoracic vein isolation[J]. Circ Arrhythm Electrophysiol,2019,12(12):e007781.
[31] 易甜甜,苏立,殷跃辉.基于心房基质的持续性心房颤动个体化消融策略[J].心血管病学进展,2017,38(5):507-511.
[32] Koruth JS,Kuroki K,Kawamura I,et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions:a preclinical assessment of safety and durability[J]. Circ Arrhythm Electrophysiol,2020,13(6):e008716.
[33] Reddy VY,Anter E,Rackauskas G,et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation:a first-in-human trial[J].Circ Arrhythm Electrophysiol,2020,13(6):e008718.
[34] Wojtaszczyk A,Caluori G,Pe?l M,et al. Irreversible electroporation ablation for atrial fibrillation[J]. J Cardiovasc Electrophysiol,2018,29(4):643-651.
[35] Dermol-?erne J,Batista Napotnik T,Reber?ek M,et al. Short microsecond pulses achieve homogeneous electroporation of elongated biological cells irrespective of their orientation in electric field[J]. Sci Rep,2020,10(1):9149.
[36] Reddy VY,Koruth J,Jais P,et al. Ablation of atrial fibrillation with pulsed?electric fields:an ultra-rapid,tissue-selective modality for cardiac ablation[J]. JACC Clin Electrophysiol,2018,4(8):987-995.
[37] van den Bos W,Scheffer HJ,Vogel JA,et al. Thermal energy during irreversible electroporation and the influence of different ablation parameters[J].J Vasc Interv Radiol,2016,27(3):433-443.
[38] Wagstaff PG,de Bruin DM,van den Bos W,et al. Irreversible electroporation of the porcine kidney:Temperature development and distribution[J].Urol Oncol,2015,33(4):168.e1-7.
[39] Agnass P, van Veldhuisen E,van Gemert MJC,et al. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro,in vivo,and clinical use:a systematic review[J]. Int J Hyperthermia,2020,37(1):486-505.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(2):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(2):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(2):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]